jueves, 28 de agosto de 2008

BYETTA (Lilly): Cuatro nuevas muertes relacionadas con el producto.

Byetta, available in the U.S. since June 2005, is Amylin's leading product, with sales that rose 17 percent in the second quarter from a year earlier. Amylin, of San Diego, and Indianapolis-based Lilly agreed to warn of the risk of pancreatitis in October, after 30 milder cases were reported.


No hay comentarios: